KOD
Price
$2.40
Change
-$0.27 (-10.11%)
Updated
Apr 3 closing price
Capitalization
140.84M
40 days until earnings call
RGNX
Price
$6.67
Change
-$0.38 (-5.39%)
Updated
Apr 3 closing price
Capitalization
334.07M
26 days until earnings call
Ad is loading...

KOD vs RGNX

Header iconKOD vs RGNX Comparison
Open Charts KOD vs RGNXBanner chart's image
Kodiak Sciences
Price$2.40
Change-$0.27 (-10.11%)
Volume$304.38K
Capitalization140.84M
REGENXBIO
Price$6.67
Change-$0.38 (-5.39%)
Volume$827.95K
Capitalization334.07M
KOD vs RGNX Comparison Chart
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. RGNX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Buy and RGNX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (KOD: $2.40 vs. RGNX: $6.67)
Brand notoriety: KOD and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 87% vs. RGNX: 94%
Market capitalization -- KOD: $140.84M vs. RGNX: $334.07M
KOD [@Biotechnology] is valued at $140.84M. RGNX’s [@Biotechnology] market capitalization is $334.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, both KOD and RGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 5 TA indicator(s) are bullish while RGNX’s TA Score has 3 bullish TA indicator(s).

  • KOD’s TA Score: 5 bullish, 2 bearish.
  • RGNX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, KOD is a better buy in the short-term than RGNX.

Price Growth

KOD (@Biotechnology) experienced а -21.57% price change this week, while RGNX (@Biotechnology) price change was -15.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

KOD is expected to report earnings on May 14, 2025.

RGNX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($334M) has a higher market cap than KOD($141M). RGNX YTD gains are higher at: -13.713 vs. KOD (-75.879). KOD has higher annual earnings (EBITDA): -164.93M vs. RGNX (-198.23M). RGNX has more cash in the bank: 235M vs. KOD (198M). KOD has less debt than RGNX: KOD (73.4M) vs RGNX (82M). RGNX has higher revenues than KOD: RGNX (83.3M) vs KOD (0).
KODRGNXKOD / RGNX
Capitalization141M334M42%
EBITDA-164.93M-198.23M83%
Gain YTD-75.879-13.713553%
P/E RatioN/AN/A-
Revenue083.3M-
Total Cash198M235M84%
Total Debt73.4M82M90%
FUNDAMENTALS RATINGS
KOD vs RGNX: Fundamental Ratings
KOD
RGNX
OUTLOOK RATING
1..100
869
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6561
P/E GROWTH RATING
1..100
10019
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (21) in the Biotechnology industry is somewhat better than the same rating for RGNX (76). This means that KOD’s stock grew somewhat faster than RGNX’s over the last 12 months.

KOD's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RGNX (100). This means that KOD’s stock grew similarly to RGNX’s over the last 12 months.

KOD's SMR Rating (98) in the Biotechnology industry is in the same range as RGNX (98). This means that KOD’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's Price Growth Rating (61) in the Biotechnology industry is in the same range as KOD (65). This means that RGNX’s stock grew similarly to KOD’s over the last 12 months.

RGNX's P/E Growth Rating (19) in the Biotechnology industry is significantly better than the same rating for KOD (100). This means that RGNX’s stock grew significantly faster than KOD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODRGNX
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFMCX23.38N/A
N/A
Hartford MidCap A
MLXAX29.56N/A
N/A
Catalyst Energy Infrastructure A
BMSLX13.90N/A
N/A
MFS Blended Research Mid Cap Eq I
VVISX11.54N/A
N/A
Vulcan Value Partners Small Cap Instl
WQDGX10.24N/A
N/A
WCM Quality Dividend Growth Investor

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with BOLD. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then BOLD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
-10.11%
BOLD - KOD
44%
Loosely correlated
-7.38%
RCKT - KOD
43%
Loosely correlated
-11.75%
IMNM - KOD
42%
Loosely correlated
-7.00%
AKBA - KOD
40%
Loosely correlated
-2.59%
RGNX - KOD
40%
Loosely correlated
-5.39%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with RCKT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-5.39%
RCKT - RGNX
52%
Loosely correlated
-11.75%
DNLI - RGNX
52%
Loosely correlated
-6.91%
NTLA - RGNX
49%
Loosely correlated
-5.62%
AXON - RGNX
48%
Loosely correlated
-3.35%
ARWR - RGNX
48%
Loosely correlated
-4.96%
More